Characterizing the Evolution of Neonatal Lung Disease Throughout Infancy and Childhood Using Electrical Impedance Tomography: A Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This study plans to learn more about ways to look at participant's lungs using new machines called Electrical Impedance Tomography (EIT). The EIT does not use harmful radiation like CT or x-ray. It is read through electrodes like using EKG reading heartbeats. The investigators want to compare the results of patients who have chronic respiratory disease to patients without chronic respiratory disease to learn more about lung structure and composition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14 days
Maximum Age: 25
Healthy Volunteers: t
View:

• 2 weeks to 25 years of age

• evidence of cardiopulmonary disease including, but not limited to:

‣ Post-prematurity respiratory disease

⁃ Congenital diaphragmatic hernia

⁃ Pulmonary Hypertension

⁃ Congenital heart disease

⁃ Respiratory failure

⁃ Neuromuscular Disease

⁃ Developmental or congenital lung disease

∙ OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease)

Locations
United States
Colorado
Children's Hospital Colorado
RECRUITING
Aurora
Contact Information
Primary
Katelyn Enzer, MD
allison.keck@childrenscolorado.org
7207779137
Backup
Allison Keck, BS
allison.keck@childrenscolorado.org
720-777-0734
Time Frame
Start Date: 2025-11
Estimated Completion Date: 2028-12
Participants
Target number of participants: 140
Treatments
Cardiopulmonary disease
Have evidence of cardiopulmonary disease including, but not limited to:~* Post-prematurity respiratory disease~* Congenital diaphragmatic hernia~* Pulmonary hypertension~* Congenital heart disease~* Respiratory failure~* Neuromuscular disease~* Developmental or congenital lung disease~May be imaged with two machines
Control
matched healthy controls with no cardiopulmonary disease
Related Therapeutic Areas
Sponsors
Collaborators: Colorado State University
Leads: University of Colorado, Denver

This content was sourced from clinicaltrials.gov